Cancer Tech Accelerator, the entrepreneur training programme from Capital Enterprise dedicated to supporting cutting-edge oncology technology commercialisation, has announced that six teams from its 2024 cohort have been accepted onto Phase II of the accelerator. ...

Image credit: Stable Diffusion Nineteen teams from Cancer Tech Accelerator came together at IDEALondon for a pitch day which saw six promising projects selected to move forward to Phase II of the programme. Now in its second year, the consortium, backed by...

We recently welcomed 11 of the top companies from the current Cancer Tech Accelerator cohort to our first-ever Demo Day. Taking place at the Royal Society of Chemistry, the event brought together the final contenders selected by our partners, Cancer Research UK,...

On 13 July, we are hosting the Cancer Tech Accelerator Demo Day where companies from the current cohort present before investors, researchers and medical experts. You’ll hear from the seven finalists teams, selected to receive £70,000 in grant funding to progress...

We are thrilled to officially announce the seven winners of the Cancer Tech Accelerator Phase II Grants, provided in partnership with Cancer Research UK, Roche UK and the Medical Research Council. These teams have been selected from a very competitive field of 50...

London, 3rd March 2022 – A 2-year life sciences entrepreneurship project part funded  by Lambeth Council’s Economic Resilience Fund is projected to contribute more than  £8 million GVA to the borough and advance breakthrough healthcare technologies.  Capital...